Med Ed Report briefs

NAAMECC, the North American Association of Medical Education and Communication Companies, changed its name to the National Association of Medical Education Companies (NAMEC). The shorter name, revealed in October, was accompanied by an updated website (namec-assn.org) and logo.

Lighthouse Learning, which develops and sells CME curricula without taking commercial support, hired Sherri Foster, CCMEP, as CME director. Foster previously was president of Scienta Healthcare Education, an accredited CME provider.

“CME Crossroads: A Survey of Continuing Medical Education Analysis, Criticism, Research and Policy Proposals” was published by Global Education Group. The peer-reviewed paper surveys key CME articles, policy papers, consensus documents and opinions between 2005 and 2010, identifying four “policy and scrutiny trends” and concluding with several recommendations.

The Alliance for CME will hold its 36th Annual Conference Jan. 26-29 in San Francisco. The theme of the meeting is the New CME—Blending Adult Learning Facilitation and Individual/Organizational Performance.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.